SelexGLM differentiates androgen and glucocorticoid receptor DNA-binding preference over an extended binding site

  1. Miles A. Pufall1
  1. 1Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA;
  2. 2Department of Biological Sciences, Columbia University, New York, New York 10027, USA;
  3. 3Department of Systems Biology, Columbia University Medical Center, New York, New York 10032, USA;
  4. 4Department of Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
  1. 5 These authors contributed equally to this work.

  • Corresponding authors: miles-pufall{at}uiowa.edu, hjb2004{at}columbia.edu
  • Abstract

    The DNA-binding interfaces of the androgen (AR) and glucocorticoid (GR) receptors are virtually identical, yet these transcription factors share only about a third of their genomic binding sites and regulate similarly distinct sets of target genes. To address this paradox, we determined the intrinsic specificities of the AR and GR DNA-binding domains using a refined version of SELEX-seq. We developed an algorithm, SelexGLM, that quantifies binding specificity over a large (31-bp) binding site by iteratively fitting a feature-based generalized linear model to SELEX probe counts. This analysis revealed that the DNA-binding preferences of AR and GR homodimers differ significantly, both within and outside the 15-bp core binding site. The relative preference between the two factors can be tuned over a wide range by changing the DNA sequence, with AR more sensitive to sequence changes than GR. The specificity of AR extends to the regions flanking the core 15-bp site, where isothermal calorimetry measurements reveal that affinity is augmented by enthalpy-driven readout of poly(A) sequences associated with narrowed minor groove width. We conclude that the increased specificity of AR is correlated with more enthalpy-driven binding than GR. The binding models help explain differences in AR and GR genomic binding and provide a biophysical rationale for how promiscuous binding by GR allows functional substitution for AR in some castration-resistant prostate cancers.

    Footnotes

    • Received March 14, 2017.
    • Accepted November 22, 2017.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    | Table of Contents

    Preprint Server